Epizyme
is a Massachusetts-based biopharmaceutical company that develops and commercializes novel epigenetic medicines for the treatment of cancer... Read moreEpizyme
is a Massachusetts-based biopharmaceutical company that develops and commercializes novel epigenetic medicines for the treatment of cancer... Read more
News
Aug 12, 2022
BioSpace
Epizyme: Ipsen Completes Acquisition of Epizyme Expanding Its Portfolio in Oncology
Aug 09, 2022
Citybizlist
Epizyme: Epizyme Reports Second Quarter 2022 Financial Results and Provides Business Update
Aug 09, 2022
Owler
Epizyme, Inc.: Epizyme's revenue changed from $75.92M in Mar 2022 to $90.44M in Jun 2022
Aug 05, 2022
centralcharts
Press Release: Epizyme : Ipsen Extends Expiration Date of Tender Offer for Epizyme, Inc. to 11 August 2022
Jul 05, 2022
MarketScreener
Epizyme: Epizyme : Statement of Changes in Beneficial Ownership (Form 4)
Jul 05, 2022
MarketScreener
Epizyme: Creative Media mmunity Trust : Material Event - Form 8-K
Jul 05, 2022
Seeking Alpha
Epizyme: Epizyme Acquisition By Ipsen: CVR Value
Jul 01, 2022
StreetInsider
Press Release: Epizyme : EPIZYME ALERT: Bragar Eagel & Squire, P.C. Investigates Merger of EPZM and Encourages Investors to Contact the Firm
Jun 28, 2022
NewsFile
Press Release: Epizyme : SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Epizyme, Inc. Merger
Jun 28, 2022
Medthority
Epizyme: Ipsen acquires Epizyme and with it Tazverik
Epizyme Competitors
1
2
3
4
5
6
7
8
9
10